Literature DB >> 15734045

Immune response versus mucosal tolerance to mucosally administered antigens.

Jiri Mestecky1, Zina Moldoveanu, Charles O Elson.   

Abstract

The enhancement of protective mucosal responses to infectious agents sought by vaccinologists, and the desired suppression of immune responses to autoantigens, allergens and food antigens induced by mucosal exposure to relevant antigens, may seem paradoxical. However, such outcomes are not mutually exclusive because of a hierarchy in the quality of immune responses: mucosal immunity manifested by the appearance of secretory antibodies and systemic tolerance manifested by diminished cell-mediated responses may be induced concomitantly. We have demonstrated that the ingestion, or nasal application, of a neo-antigen-keyhole limpet hemocyanin (KLH)-primes human volunteers for subsequent humoral mucosal and systemic responses induced by systemic immunization but suppresses cell-mediated responses (T cell proliferation and delayed-type hypersensitivity). Furthermore, extended ingestion of selected food antigens diminished, but did not totally suppress, cell-mediated immunity and levels of serum antibodies while salivary antibodies were easily detectable. Most importantly, the humoral and cellular immune responses induced by systemic immunization with KLH could not be suppressed by subsequent extended ingestion of large doses of the same antigen. Thus, ongoing systemic responses are refractory to the induction of mucosal tolerance in humans. This finding is of considerable importance for the development of and sequence of immunization with mucosally administered vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734045     DOI: 10.1016/j.vaccine.2004.11.009

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Delivery of DNA HIV-1 vaccine to the liver induces high and long-lasting humoral immune responses.

Authors:  Milan Raska; Zina Moldoveanu; Jan Novak; Zdenek Hel; Lea Novak; Jadranka Bozja; Richard W Compans; Chinglai Yang; Jiri Mestecky
Journal:  Vaccine       Date:  2008-02-07       Impact factor: 3.641

2.  Association of NOD1 (CARD4) insertion/deletion polymorphism with susceptibility to IBD: a meta-analysis.

Authors:  Wei-Guo Lu; Yan-Feng Zou; Xiao-Liang Feng; Feng-Lai Yuan; Yuan-Long Gu; Xia Li; Cheng-Wan Li; Cheng Jin; Jian-Ping Li
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

3.  The unexplored roles of human serum IgA.

Authors:  Ka Wai Leong; Jeak Ling Ding
Journal:  DNA Cell Biol       Date:  2014-12       Impact factor: 3.311

Review 4.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

5.  PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity.

Authors:  Chantal Keijzer; Bram Slütter; Ruurd van der Zee; Wim Jiskoot; Willem van Eden; Femke Broere
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

6.  Bacterial Toxin Fusion Proteins Elicit Mucosal Immunity against a Foot-and-Mouth Disease Virus Antigen When Administered Intranasally to Guinea Pigs.

Authors:  Sreerupa Challa; Steven M Szczepanek; Debra Rood; Roger W Barrette; Lawrence K Silbart
Journal:  Adv Virol       Date:  2011-09-22

7.  Dysregulation of Systemic and Mucosal Humoral Responses to Microbial and Food Antigens as a Factor Contributing to Microbial Translocation and Chronic Inflammation in HIV-1 Infection.

Authors:  Zdenek Hel; Jun Xu; Warren L Denning; E Scott Helton; Richard P H Huijbregts; Sonya L Heath; E Turner Overton; Benjamin S Christmann; Charles O Elson; Paul A Goepfert; Jiri Mestecky
Journal:  PLoS Pathog       Date:  2017-01-26       Impact factor: 6.823

8.  Collagen V-induced nasal tolerance downregulates pulmonary collagen mRNA gene and TGF-beta expression in experimental systemic sclerosis.

Authors:  Ana Paula P Velosa; Walcy R Teodoro; Daniel M dos Anjos; Renata Konno; Cristiane C Oliveira; Maria L H Katayama; Edwin R Parra; Vera L Capelozzi; Natalino H Yoshinari
Journal:  Respir Res       Date:  2010-01-04

9.  Vascularized composite allograft rejection is delayed by intrajejunal treatment with donor splenocytes without concomitant immunosuppressants.

Authors:  Christopher Glenn Wallace; Chia-Hung Yen; Hsiang-Chen Yang; Chun-Yen Lin; Ren-Chin Wu; Wei-Chao Huang; Jeng-Yee Lin; Fu-Chan Wei
Journal:  Clin Dev Immunol       Date:  2012-11-27

10.  Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration.

Authors:  Natalija Budimir; Aalzen de Haan; Tjarko Meijerhof; Emma Gostick; David A Price; Anke Huckriede; Jan Wilschut
Journal:  Influenza Other Respir Viruses       Date:  2013-09-16       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.